Research

Marsha Campbell-Yeo, a professor in Dal's School of Nursing, has undertaken a study looking into how families have coped with the new rules in Neonatal Intensive Care Units across Canada.

With the U.S. election now over and president-elect Joe Biden trying to create an orderly transition plan amid continued false accusations of election fraud from President Donald Trump, panelists from a Dal-hosted Open Dialogue event last month have returned to share their reactions.

There are effective ways to help reduce babies' pain during blood draws and injections, but they are used in less than 50 percent of routine medical procedures involving newborns, write Dalhousie's Marsha Campbell-Yeo and St. Francis Xavier University's Britney Benoit.

Drugmaker Pfizer's news this week that its experimental vaccine is more than 90 percent effective in preventing COVID-19 was met with much jubilance. Dr. Scott Halperin, a professor in the Division of Infectious Diseases, explains what comes next in Pfizer's large-scale clinical trial, how significant a 90 percent efficacy rate is, and how vaccines will be distributed.

Researchers at Dal, the IWK Health Centre and the QEII Health Sciences Centre have received $1.2 million in funding from the Canada Foundation for Innovation to advance the development of new COVID-19 vaccines with upgrades to the Canadian Centre for Vaccinology’s level 3 containment facility at the IWK Health Centre.